Literature DB >> 17926584

Myosin heavy chain composition and fiber size of the cricopharyngeus muscle in patients with achalasia and normal subjects.

Melinda V Davis1, Albert L Merati, Safwan S Jaradeh, Joel H Blumin.   

Abstract

OBJECTIVES: Cricopharyngeal achalasia (CA) can be defined as inadequate opening of the cricopharyngeus muscle (CPM) resulting in dysphagia. Myosin heavy chain (MHC) isoform fiber type composition and size are key determinants of muscle function. These parameters have not been described in CA. It is hypothesized that there is a difference between the MHC isoform composition of the CPM in patients with the clinical diagnosis of CA and that in normal subjects.
METHODS: Patients who had received prior botulinum were excluded. The MHC fiber type composition and size in patients and cadaveric controls were determined by adenosine triphosphatase staining and image analysis.
RESULTS: The CPMs of 12 CA patients (6 male, 6 female; mean age, 61 years) and 5 control cadaveric subjects (3 male, 2 female; mean age, 67 years) were analyzed. There were relatively fewer type I fibers (67%) in patients with CA than in controls (81%), but the difference was not significant (p = .18). Type I fibers were slightly smaller in CA patients (38.7 microm) than in controls (47.2 microm), but this was not significantly different (p > .05). Of the 12 CA patients, 3 had type II predominance, a feature not seen in normal subjects.
CONCLUSIONS: Patients with CA had relatively fewer type I fibers, although the difference was not statistically significant. The MHC isoform composition and fiber size were not different between CA patients and normal subjects. This is the first report to characterize the CPM in patients with CA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17926584     DOI: 10.1177/000348940711600903

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  4 in total

1.  Ageing and muscular dystrophy differentially affect murine pharyngeal muscles in a region-dependent manner.

Authors:  Matthew E Randolph; Qingwei Luo; Justin Ho; Katherine E Vest; Alan J Sokoloff; Grace K Pavlath
Journal:  J Physiol       Date:  2014-10-17       Impact factor: 5.182

2.  Natural History of Cricopharyngeus Muscle Dysfunction Symptomatology.

Authors:  Derrick R Randall; Ryan Chan; Dayani Gomes; Kim Walker
Journal:  Dysphagia       Date:  2021-09-08       Impact factor: 2.733

Review 3.  Botulinum Toxin Injection for the Treatment of Upper Esophageal Sphincter Dysfunction.

Authors:  Pengxu Wei
Journal:  Toxins (Basel)       Date:  2022-04-30       Impact factor: 5.075

4.  Botulinum toxin injection for the treatment of upper esophageal sphincter dysfunction.

Authors:  Elizabeth A Kelly; Ian J Koszewski; Safwan S Jaradeh; Albert L Merati; Joel H Blumin; Jonathan M Bock
Journal:  Ann Otol Rhinol Laryngol       Date:  2013-02       Impact factor: 1.547

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.